{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["9(10)"],"submitter":["Sultana A"],"pubmed_abstract":["The Oxford-AstraZeneca vaccine (Covishield) was the first to be introduced in Bangladesh to fight the ongoing global COVID-19 pandemic. As this vaccine had shown some side-effects in its clinical trial, we aimed to conduct a study assessing short-term adverse events following immunization (AEFIs) in Bangladesh. A cross-sectional study was conducted on social and electronic media platforms by delivering an online questionnaire among people who had taken at least one dose of the COVID-19 vaccine. The collected data were then analysed to evaluate various parameters related to the AEFIs of the respondents. A total of 626 responses were collected. Of these, 623 were selected based on complete answers and used for the analysis. Most of the respondents were between 30-60 years of age, and 40.4% w"],"journal":["Vaccines"],"pagination":["1090"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8538494"],"repository":["biostudies-literature"],"pubmed_title":["A Retrospective Cross-Sectional Study Assessing Self-Reported Adverse Events following Immunization (AEFI) of the COVID-19 Vaccine in Bangladesh."],"pmcid":["PMC8538494"],"pubmed_authors":["Saha A","Shahriar S","Chowdhury AA","Fatema KR","Buyuker SM","Kabir S","Sarker MMR","Ferdousy S","Samodder M","Tahsin MR","Mim SR","Rahman MM","Kuddus MR","Hossain MA","Mamun MAH","Akter T","Amran MS","Bahar NB","Sultana A","Yesmin F","Aktar F","Chowdhury JA","Aknur Rahman M"],"additional_accession":[]},"is_claimable":false,"name":"A Retrospective Cross-Sectional Study Assessing Self-Reported Adverse Events following Immunization (AEFI) of the COVID-19 Vaccine in Bangladesh.","description":"The Oxford-AstraZeneca vaccine (Covishield) was the first to be introduced in Bangladesh to fight the ongoing global COVID-19 pandemic. As this vaccine had shown some side-effects in its clinical trial, we aimed to conduct a study assessing short-term adverse events following immunization (AEFIs) in Bangladesh. A cross-sectional study was conducted on social and electronic media platforms by delivering an online questionnaire among people who had taken at least one dose of the COVID-19 vaccine. The collected data were then analysed to evaluate various parameters related to the AEFIs of the respondents. A total of 626 responses were collected. Of these, 623 were selected based on complete answers and used for the analysis. Most of the respondents were between 30-60 years of age, and 40.4% w","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Sep","modification":"2025-04-19T15:10:33.401Z","creation":"2025-04-19T15:10:33.401Z"},"accession":"S-EPMC8538494","cross_references":{"pubmed":["34696198"],"doi":["10.3390/vaccines9101090"]}}